# COVID-19 Testing in Underserved and Vulnerable Populations

> **NCT05315908** · NA · TERMINATED · sponsor: **Jesse Nodora** · enrollment: 9120 (actual)

## Conditions studied

- Heart Failure
- Coronary Artery Disease
- Cancer
- Chronic Kidney Diseases
- COPD
- Obesity
- Sickle Cell Disease
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** Community outreach method

## Key facts

- **NCT ID:** NCT05315908
- **Lead sponsor:** Jesse Nodora
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 9120 (ACTUAL)
- **Why stopped:** Because of low testing uptake, slow accrual at participating health centers and continuously changing COVID pandemic, research investigators had to terminate the original study and consider alternate strategies.
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05315908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05315908, "COVID-19 Testing in Underserved and Vulnerable Populations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05315908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*